News

Precision medicine company falls into administration

Oncimmune, a precision medicine company, has fallen into administration. It follows attempts by the business to sell its German trading subsidiary and a failure to...

Mallinckrodt and Endo to combine in $6.7 billion merger

Mallinckrodt and Endo have entered into a definitive agreement to combine in a $6.7 billion deal, after the companies emerged from bankruptcy in connection...

Merck opens $1bn facility to increase vaccine production capacity

Merck (known as MSD outside of the United States and Canada) has opened a new, $1 billion, 225,000 sq ft facility dedicated to vaccine...